Natural killer cell therapy for b-cell lymphoma that has returned
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tests whether adding your own natural killer (nk) cells (a type of immune cell) to your regular treatment helps fight non-hodgkin lymphoma that has come back or not responded. The goal is to see if this extra treatment is safe and works better at stopping the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 15 to 80 years old.
- You have a type of non-hodgkin lymphoma that started in b-cells.
- You have had lymphoma that came back or did not go away after treatment.
- You have at least one measurable tumor spot (at least 1.5 cm wide) on a ct scan.
- If you are a woman who can become pregnant, you must have a negative pregnancy test and agree not to get pregnant for 2 years.
- If you are a man who can have children, you must agree to use an effective barrier contraceptive.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using immune cells from cord blood, called CAR NK cells, to fight certain types of B-cell lymphoma that have come back or not responded to other treatments. It is designed for people who have tried at least two prior therapies.
This trial tests a treatment using natural killer (NK) cells combined with antibodies to fight a type of blood cancer called acute myeloid leukemia (AML). It is for people whose AML has come back or not improved with standard treatments.
This trial tests a new combination of specially grown immune cells (NK cells) plus two drugs that help them attack cancer. It's for people with a type of B-cell lymphoma that came back after at least two prior treatments or a stem cell transplant, and who have either failed or are not eligible for CAR-T cell therapy.
This study tests a new treatment using natural killer (NK) cells that are specially created in the lab to find and attack cancer cells that have a protein called CD5 on their surface. The treatment is given along with chemotherapy to help the NK cells work better. It may be an option for people with certain types of T-cell lymphoma or leukemia that have not responded to other treatments.
This trial tests a new type of immune cell therapy (NK cells) for patients with malignant brain tumors that have come back or worsened despite previous treatment. The goal is to see if these specially prepared immune cells can help fight the cancer.
This trial tests a new type of immune cell called natural killer (NK) cells from healthy donors to treat neuroblastoma that has not responded to standard treatments. The goal is to see if these cells can help shrink or control the cancer.
Hear when a new NK Cell trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.